Correlation Between ZyVersa Therapeutics and Bright Minds

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Bright Minds Biosciences, you can compare the effects of market volatilities on ZyVersa Therapeutics and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Bright Minds.

Diversification Opportunities for ZyVersa Therapeutics and Bright Minds

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between ZyVersa and Bright is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Bright Minds go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Bright Minds

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Bright Minds. But the stock apears to be less risky and, when comparing its historical volatility, ZyVersa Therapeutics is 1.42 times less risky than Bright Minds. The stock trades about -0.17 of its potential returns per unit of risk. The Bright Minds Biosciences is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  3,678  in Bright Minds Biosciences on November 18, 2024 and sell it today you would earn a total of  502.00  from holding Bright Minds Biosciences or generate 13.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ZyVersa Therapeutics  vs.  Bright Minds Biosciences

 Performance 
       Timeline  
ZyVersa Therapeutics 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ZyVersa Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, ZyVersa Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Bright Minds Biosciences 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bright Minds Biosciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Bright Minds reported solid returns over the last few months and may actually be approaching a breakup point.

ZyVersa Therapeutics and Bright Minds Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ZyVersa Therapeutics and Bright Minds

The main advantage of trading using opposite ZyVersa Therapeutics and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.
The idea behind ZyVersa Therapeutics and Bright Minds Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA